AXA Investment Managers’s IDEAYA Biosciences IDYA Stock Holding History

AXA Investment Managers’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$8.86M	Buy	+325,513	New	+$7.87M	0.02%	436

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

AXA Investment Managers's IDYA Position: Q3 2025 in Review

AXA Investment Managers opened a new position in IDEAYA Biosciences (IDYA) in Q3 2025: 325,513 shares worth $8.86M. The stake represents 0.02% of the portfolio and ranks #436 among its holdings.

224 funds tracked by Wall St. Rank hold IDYA as of Q3 2025.

AXA Investment Managers held 325,513 shares of IDEAYA Biosciences worth $8.86M as of Q3 2025.
IDEAYA Biosciences was a new AXA Investment Managers position in Q3 2025.
IDEAYA Biosciences made up 0.02% of AXA Investment Managers's portfolio in Q3 2025, its #436 holding.
224 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.